139 related articles for article (PubMed ID: 25200610)
1. A gradient-loadable (64)Cu-chelator for quantifying tumor deposition kinetics of nanoliposomal therapeutics by positron emission tomography.
Lee H; Zheng J; Gaddy D; Orcutt KD; Leonard S; Geretti E; Hesterman J; Harwell C; Hoppin J; Jaffray DA; Wickham T; Hendriks BS; Kirpotin D
Nanomedicine; 2015 Jan; 11(1):155-65. PubMed ID: 25200610
[TBL] [Abstract][Full Text] [Related]
2. Companion Diagnostic
Lee H; Gaddy D; Ventura M; Bernards N; de Souza R; Kirpotin D; Wickham T; Fitzgerald J; Zheng J; Hendriks BS
Theranostics; 2018; 8(9):2300-2312. PubMed ID: 29721081
[TBL] [Abstract][Full Text] [Related]
3.
Lee H; Shields AF; Siegel BA; Miller KD; Krop I; Ma CX; LoRusso PM; Munster PN; Campbell K; Gaddy DF; Leonard SC; Geretti E; Blocker SJ; Kirpotin DB; Moyo V; Wickham TJ; Hendriks BS
Clin Cancer Res; 2017 Aug; 23(15):4190-4202. PubMed ID: 28298546
[No Abstract] [Full Text] [Related]
4. Liposomal
Blocker SJ; Douglas KA; Polin LA; Lee H; Hendriks BS; Lalo E; Chen W; Shields AF
Theranostics; 2017; 7(17):4229-4239. PubMed ID: 29158822
[TBL] [Abstract][Full Text] [Related]
5. Remote Loading of (64)Cu(2+) into Liposomes without the Use of Ion Transport Enhancers.
Henriksen JR; Petersen AL; Hansen AE; Frankær CG; Harris P; Elema DR; Kristensen AT; Kjær A; Andresen TL
ACS Appl Mater Interfaces; 2015 Oct; 7(41):22796-806. PubMed ID: 26426093
[TBL] [Abstract][Full Text] [Related]
6. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
[TBL] [Abstract][Full Text] [Related]
7. Novel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imaging.
Li S; Goins B; Zhang L; Bao A
Bioconjug Chem; 2012 Jun; 23(6):1322-32. PubMed ID: 22577859
[TBL] [Abstract][Full Text] [Related]
8. Encapsulation and retention of chelated-copper inside hydrophobic nanoparticles: Liquid cored nanoparticles show better retention than a solid core formulation.
Hervella P; Parra E; Needham D
Eur J Pharm Biopharm; 2016 May; 102():64-76. PubMed ID: 26925504
[TBL] [Abstract][Full Text] [Related]
9. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
[TBL] [Abstract][Full Text] [Related]
10. Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage.
Shmeeda H; Tzemach D; Mak L; Gabizon A
J Control Release; 2009 Jun; 136(2):155-60. PubMed ID: 19331844
[TBL] [Abstract][Full Text] [Related]
11. Ultrasmall [(64)Cu]Cu nanoclusters for targeting orthotopic lung tumors using accurate positron emission tomography imaging.
Gao F; Cai P; Yang W; Xue J; Gao L; Liu R; Wang Y; Zhao Y; He X; Zhao L; Huang G; Wu F; Zhao Y; Chai Z; Gao X
ACS Nano; 2015 May; 9(5):4976-86. PubMed ID: 25919205
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography: a novel technique for investigating the biodistribution and transport of nanoparticles.
Palko HA; Fung JY; Louie AY
Inhal Toxicol; 2010 Jul; 22(8):657-88. PubMed ID: 20373851
[TBL] [Abstract][Full Text] [Related]
13. Liposomal Cu-64 labeling method using bifunctional chelators: poly(ethylene glycol) spacer and chelator effects.
Seo JW; Mahakian LM; Kheirolomoom A; Zhang H; Meares CF; Ferdani R; Anderson CJ; Ferrara KW
Bioconjug Chem; 2010 Jul; 21(7):1206-15. PubMed ID: 20568726
[TBL] [Abstract][Full Text] [Related]
14. Nuclear and Fluorescent Labeled PD-1-Liposome-DOX-
Du Y; Liang X; Li Y; Sun T; Jin Z; Xue H; Tian J
Mol Pharm; 2017 Nov; 14(11):3978-3986. PubMed ID: 29016143
[TBL] [Abstract][Full Text] [Related]
15. Development of PET Radioisotope Copper-64-Labeled Theranostic Immunoliposomes for EGFR Overexpressing Cancer-Targeted Therapy and Imaging.
Jeong HY; Kang SJ; Kim MW; Jeong IH; Choi MJ; Jung C; Song IH; Lee TS; Park YS
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339090
[TBL] [Abstract][Full Text] [Related]
16. Albumin Nanoparticles Increase the Efficacy of Doxorubicin Hydrochloride Liposome Injection Based on Threshold Theory.
Lin W; Li A; Qiu L; Huang H; Cui P; Wang J
Mol Pharm; 2024 Jun; 21(6):2970-2980. PubMed ID: 38742943
[TBL] [Abstract][Full Text] [Related]
17. In vivo evaluation of PEGylated ⁶⁴Cu-liposomes with theranostic and radiotherapeutic potential using micro PET/CT.
Petersen AL; Henriksen JR; Binderup T; Elema DR; Rasmussen PH; Hag AM; Kjær A; Andresen TL
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):941-952. PubMed ID: 26646780
[TBL] [Abstract][Full Text] [Related]
18. 64Cu loaded liposomes as positron emission tomography imaging agents.
Petersen AL; Binderup T; Rasmussen P; Henriksen JR; Elema DR; Kjær A; Andresen TL
Biomaterials; 2011 Mar; 32(9):2334-41. PubMed ID: 21216003
[TBL] [Abstract][Full Text] [Related]
19. Positron Emission Tomography Based Elucidation of the Enhanced Permeability and Retention Effect in Dogs with Cancer Using Copper-64 Liposomes.
Hansen AE; Petersen AL; Henriksen JR; Boerresen B; Rasmussen P; Elema DR; af Rosenschöld PM; Kristensen AT; Kjær A; Andresen TL
ACS Nano; 2015 Jul; 9(7):6985-95. PubMed ID: 26022907
[TBL] [Abstract][Full Text] [Related]
20. Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines.
Edmonds S; Volpe A; Shmeeda H; Parente-Pereira AC; Radia R; Baguña-Torres J; Szanda I; Severin GW; Livieratos L; Blower PJ; Maher J; Fruhwirth GO; Gabizon A; T M de Rosales R
ACS Nano; 2016 Nov; 10(11):10294-10307. PubMed ID: 27781436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
